Literature DB >> 31875574

The effect of peroxymonosulfate in WS2 nanosheets for the removal of diclofenac: Information exposure and degradation pathway.

Zhen Chen1, Shaoxiong He2, Mingshan Zhu2, Chaohai Wei3.   

Abstract

The search for a suitable heterogeneous catalyst in peroxymonosulfate (PMS) activation holds tremendous promise for the degradation of organic pollutants. Two-dimensional (2D) transition metal dichalcogenides such as WS2 exhibit broad applications in heterogeneous catalysis, and we first extended its application in PMS activation in this work. It was found that WS2 could efficiently activate PMS resulting in the degradation of diclofenac (DCF). The results show that the PMS offers direct oxidation, and WS2 could initiate PMS to produce singlet oxygen (1O2) and superoxide radical (·O2-). This resulted in the improved removal of DCF in the WS2/PMS system. Furthermore, the degradation pathway of DCF was proposed according to the detected intermediates/products and density functional theory (DFT) calculation. Degradation intermediates and the evaluation of product toxicity indicated that the developed WS2/PMS system was a safe and detoxifying process while also offering efficient DCF removal. This study offers more insight into the development of suitable materials for the activation of PMS and gives clear direction for the degradation of DCF and its toxic intermediates.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Density functional theory; Diclofenac; Peroxymonosulfate; Toxicity evaluation; WS(2) nanosheet

Mesh:

Substances:

Year:  2019        PMID: 31875574     DOI: 10.1016/j.chemosphere.2019.125678

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  1 in total

1.  Immobilizing a visible light-responsive photocatalyst on a recyclable polymeric composite for floating and suspended applications in water treatment.

Authors:  Ch Tahir Mehmood; Ziyi Zhong; Hua Zhou; Chenchen Zhang; Yeyuan Xiao
Journal:  RSC Adv       Date:  2020-10-01       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.